Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Sperling, MD
Thomas Jefferson University
Principal Investigator - Robert Gross, MD, PhD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Stanford University
Palo Alto, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
- University of Miami
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Louisville Hospital
Louisville, Kentucky, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Rutgers University - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Northwell Health
Great Neck, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Ohio Health Research Institute
Columbus, Ohio, United States
- Oregon Health & University Science
Portland, Oregon, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- the University of Texas Health Science Center at Houston
Houston, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
- University of Washington Harborview
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 11 Dec 2023
- Completion
- 11 Dec 2023
- Last update posted
- 17 Jan 2025
- Registered enrollment
- 167
- Registry id
- NCT02844465
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.